Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Immune System Diseases
AbbVie to buy Landos Biopharma for up to $212M
By
LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
CRISPR may enable rapid, sensitive test for COVID-19
By
Joseph Constance
The device has the potential for use as a diagnostic test at the point of care (POC), according to its developers.
September 26, 2022
N-antigen levels point to COVID severity in NIH study
By
Jared Berberabe
The study by researchers at the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) was a cross-sectional follow-up analysis involving 2,540 participants who had been previously enrolled in the Therapeutics for Inpatients with COVID-19 (TICO) platform trial.
September 8, 2022
Lunaphore, Nucleai to provide AI-based spatial biology analysis
By
LabPulse.com staff writers
Combining Lunaphore's Comet hyperplex staining and imaging platform, a fully automated sequential immunofluorescence (seqIF) instrument, with Nucleai's Atom artificial-intelligence (AI) spatial biology platform will enable the companies to generate new insights from tissue biopsies and provide labs with an integrated end-to-end spatial biology workflow.
September 8, 2022
Week in Review: Room-temperature CRISPR, Roche T-cell test for COVID response, Qiagen monkeypox syndromic panel, and more
By
Leo O'Connor
Dear LabPulse.com member,
August 17, 2022
Qiagen marks milestone for TB blood test
By
LabPulse.com staff writers
The fourth-generation QuantiFeronTB Gold Plus assay is being used to test patients in over 130 countries, the company said. It identifies interferon-gamma released by T cells after recognizing TB-specific antigens as a marker of TB infection.
March 23, 2022
'Rogue antibodies' hint at severe COVID risk
By
Leah Sherwood
The goal of the study was to identify circulating factors, such as hormones and antibodies, in COVID-19 patients that contribute to the activation and dysfunction of endothelial cells, which are the main type of cell found in the inside lining of blood vessels, lymph vessels, and the heart.
February 16, 2022
AMP 2021 meeting puts spotlight back on cancer
By
Bruce Carlson
Seminars at AMP 2021 focused on technologies and techniques to help detect and profile tumors, with special emphasis on hard-to-detect cancer cells that remain in patients after treatment.
November 22, 2021
Qiagen debuts solution for SARS-CoV-2 T-cell research
By
LabPulse.com staff writers
QuantiFeron SARS-CoV-2 ROU is a modular system based on the platform Qiagen developed for its QuantiFeron-TB Gold Plus test for latent tuberculosis.
December 6, 2020
Vaccines won't eliminate the need for COVID-19 testing
By
Bruce Carlson
It may be natural to suspect that if a vaccine is available, there will be fewer cases thus less reason to test. But this isn't normally the interplay between vaccines and diseases.
November 23, 2020
Who should get the 1st COVID-19 vaccines?
By
Leah Sherwood
Current strategic prioritization plans emphasize the importance of vaccinating healthcare workers, since doing so preserves the healthcare system itself. Another priority is to directly protect the elderly and people with comorbidities, who are at the highest risk of death or hospitalization from COVID-19.
October 25, 2020
Interleukin-6 testing grows rapidly, with limited evidence of utility
By
David Grenache, PhD
Cytokines are small proteins released by many different types of cells, including the white blood cells of the immune system. Cytokines help regulate the immune system's response to an infection and cause inflammation. The storm happens when the release of cytokines goes into an uncontrolled overdrive causing hyperinflammation which damages the body's organs. In the lungs, this inflammation causes fluid to accumulate in the airspaces which then leads to ARDS.
June 8, 2020
Page 1 of 3
Next Page